CDC: Only Half of U.S. Nursing Home Residents Have Received Boosters
TUESDAY, Dec. 14, 2021 (HealthDay News) — As COVID-19 cases surge nationwide, only about half of fully vaccinated nursing home residents have received a vaccine booster dose, the U.S. Centers for Disease Control and Prevention reports.Research shows …
Learn MoreOmicron Resists Pfizer Vaccine but Causes Less Severe Disease
TUESDAY, Dec. 14, 2021 (HealthDay News) — Compared with previous coronavirus variants, omicron appears to cause less severe illness, but is more resistant to the Pfizer vaccine, researchers at South Africa’s largest health insurer report.The team at …
Learn MoreCalifornia Brings Back Indoor Mask Mandate
TUESDAY, Dec. 14, 2021 (HealthDay News) — A statewide indoor mask mandate will be reintroduced in California on Wednesday and last one month, officials in America’s largest state said Monday.”To ensure that we collectively protect the health and well…
Learn MoreDetection Rate High for PET-PSMA in Advanced Prostate Cancer With Ongoing ADT
MONDAY, Aug. 2, 2021 (HealthDay News) — For patients with advanced prostate cancer receiving ongoing androgen deprivation therapy (ADT), positron emission tomography (PET) with prostate-specific membrane antigen (PSMA) has a high detection rate, according to a study published online June 29 in the Annals of Nuclear Medicine.
Saskia Fassbind, from the University of Zurich, and colleagues examined the detection rate and distribution of lesions using PSMA PET imaging in patients with advanced prostate cancer and ongoing ADT. Eighty-four patients with hormone-sensitive or hormone-resistant prostate cancer underwent 68Gallium [Ga]-PSMA-11 PET/magnetic resonance [MR] imaging or computed tomography. The detection of PSMA-positive lesions was examined overall and for three prostate-specific antigen (PSA) subgroups.
The researchers found that 94.0 percent of all patients had PSMA-positive lesions. According to PSA subgroup, the detection rates were 85.2, 97.3, and 100 percent for 0 to 20 ng/mL, respectively. Only patients with a PSA >1 ng/mL had PSMA-positive visceral metastases. There was no difference observed in detection of PSMA-positive lesions for those with hormone-sensitive or hormone-resistant prostate cancer. Nineteen (22.6 percent) of the patients had oligometastatic prostate cancer; almost all of these patients would have been eligible for metastasis-directed radiotherapy (94.7 percent).
“In this retrospective study analyzing the detection rate of 68Ga-PSMA-11 PET/CT or PET/MR in patients with advanced prostate cancer and ongoing ADT, we found a high overall detection rate of 94.0 percent,” the authors write.
Learn MoreBritish Study Shows Vaccines Weaken Against Omicron, but Boosters Help
MONDAY, Dec. 13, 2021 (HealthDay News) — The ability of two-dose COVID-19 vaccines to protect against symptomatic infection by the omicron variant falls significantly short, but a booster shot provides considerable protection, according to the first …
Learn MoreU.S. COVID-19 Death Toll Passes 800,000
MONDAY, Dec. 13, 2021 (HealthDay News) — The COVID-19 death toll in the United States reached 800,000 on Monday, and one expert believes it will likely hit 1 million at some point in 2022.The 800,156 confirmed deaths in the nearly two years since the…
Learn MoreReport Shows World Ill-Prepared for Next Pandemic
MONDAY, Dec. 13, 2021 (HealthDay News) — The world is not ready to prevent or deal with another pandemic because many nations are not taking the necessary steps to prepare for what is likely an inevitable future scenario, a new report shows. The Glob…
Learn MoreRadiological Society of North America, Nov. 28-Dec. 2
The annual meeting of the Radiological Society of North America was held from Nov. 28 to Dec. 2 in Chicago and attracted more than 19,000 participants from around the world, including radiologists, radiation oncologists, physicists in medicine, radiol…
Learn MorePhysician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Dec. 6 to 10, 2021. This roundup includes the latest research news from journal studies and other trusted sour…
Learn MoreHalf of U.S. Parents of Teens Got Their Child Vaccinated, but Uptake Slows
FRIDAY, Dec. 10, 2021 (HealthDay News) — Nearly half of 12- to 17-year-olds in the United States have had at least one COVID-19 vaccine shot, but the initial rush to get teens immunized has stalled, a new survey of parents shows. Only 1 percent of pa…
Learn More